News

Heptares Therapeutics (“Heptares”), a wholly owned subsidiary of Sosei Group Corporation (“Sosei”; TSE Mothers Index: 4565), is delighted that one of its founders, Richard Henderson (MRC Laboratory of Molecular Biology, Cambridge, UK), was awarded the Nobel Prize in Chemistry...

ProBioGen AG, a premier service & technology provider for complex therapeutic glycoproteins and Chiome Bioscience Inc., a Japanese antibody discovery and development company, today jointly announced signing a service and license agreement. Under the agreement ProBioGen...

Lonza is hosting a free 60-minute webinar on 24 October 2017, titled “Challenges and Strategies for Paperless Product Release – Bringing the Pieces Together.” In a regulated manufacturing environment, production and quality tend to work in...

Recipharm is proud to announce that our programme designed to implement our standard solution for serialisation across our manufacturing facilities, has been recognised as an example of best practice at the TRACKTS Awards 2017. The programme...

Copenhagen, Denmark: Albumedix has announced that it has signed a strategic research agreement with Oslo University Hospital and University of Oslo. The three organisations will work together to improve understanding of the interaction between bioengineered albumin variants and the...

Worldwide Clinical Trials Experts to ExploreEmerging Trends in Cardiovascular Research in Webinar Commemorating World Heart Day. Worldwide Clinical Trials’ Director of Global Patient Recruitment and Retention, Barbara Zupancic, will present “Improving Patient Engagement in Alzheimer’s Disease...

Worldwide Clinical Trials will host the next in its series of ‘Eavesdropping on the Experts’ webinars titled, Five Emerging Trends in Cardiovascular Research”on September 28th at 11am ET in commemoration of World Heart Day (September 29th). ...